The transcription factor Kruppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma

被引:25
|
作者
An, Tingting [1 ]
Dong, Tianxiu [1 ]
Zhou, Haoxin [2 ]
Chen, Yaodong [1 ]
Zhang, Jiuwei [1 ]
Zhang, Yu [1 ]
Li, Zizhuo [1 ]
Yang, Xiuhua [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Abdominal Ultrasound, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Emergency Surg, Harbin 150001, Heilongjiang, Peoples R China
关键词
Kruppel-like factor 5; Hepatocellular carcinoma; Proliferation; Migration; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-METASTASIS; CANCER CELLS; KLF5; APOPTOSIS; PATHWAY; PROLIFERATION; INVASION;
D O I
10.1016/j.bbrc.2018.11.084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor Kruppel-like factor 5 (KLF5) is highly expressed in many cancers and serves as a prognostic factor. However, the function of KLF5 in hepatocellular carcinoma (HCC) is unclear. In this study, we found that KLF5 was significantly overexpressed in HCC cell lines and specimens, and high KLF5 expression predicted a poor prognosis for HCC patients. Then, we studied the effects of KLF5 on the proliferation, apoptosis, migration and invasion of HCC cells in vitro and vivo. The inhibition of KLF5 markedly inhibited HCC growth and metastasis, while KLF5 overexpression promoted these processes. In addition, we observed that KLF5 could promote the epithelial-mesenchymal transition (EMT) in HCC via the PI3K/AKT/Snail signaling pathway. The silencing of KLF5 in HCC cell lines downregulated the expression of N-cadherin, Vimentin and Snail and increased the expression of the epithelial marker E-cadherin. The expression of MMP2 and MMP9 was also decreased in KLF5-silenced HCC cells. However, opposite results were observed in the KLF5-overexpressing group. These results indicate that KLF5 plays a significant role in HCC progression and metastasis and induces EMT via activating PI3K/AKT/Snail signaling, and the inhibition of KLF5 may be a potential treatment modality for patients with HCC. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:159 / 168
页数:10
相关论文
共 50 条
  • [31] HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis
    Li, X.
    Zhang, N-X
    Ye, H-Y
    Song, P-P
    Chang, W.
    Chen, L.
    Wang, Z.
    Zhang, L.
    Wang, N-N
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (10) : 4126 - 4135
  • [32] Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway
    Tang, Junming
    Wang, Jianing
    Kong, Xia
    Yang, Jianye
    Guo, Linyun
    Zheng, Fei
    Zhang, Lei
    Huang, Yongzhang
    Wan, Yu
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (20) : 3521 - 3531
  • [33] TAF1D promotes tumorigenesis and metastasis by activating PI3K/AKT/mTOR signaling in clear cell renal cell carcinoma
    Hu, Xuan
    Chen, Liang
    Liu, Tao
    Wan, Ziyu
    Yu, Hua
    Tang, Feng
    Shi, Jiageng
    Chen, Zhizhuang
    Wang, Xinghuan
    Yang, Zhonghua
    CELLULAR SIGNALLING, 2024, 124
  • [34] Tumor necrosis factor receptor 2 promotes growth of colorectal cancer via the PI3K/AKT signaling pathway
    Zhao, Tao
    Li, Huihui
    Liu, Zifeng
    ONCOLOGY LETTERS, 2017, 13 (01) : 342 - 346
  • [35] Limonin provokes hepatocellular carcinoma cells with stemness entry into cycle via activating PI3K/Akt signaling
    Tang, Zhenyong
    Tang, Yuntian
    Li, Lei
    Liu, Tianqi
    Yang, Jianrong
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [36] RETRACTED: ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway (Retracted Article)
    Yin, Hui
    Wang, Lunqing
    Li, Fei
    Wang, Dongfei
    Zhang, Zhe
    Yu, Bentong
    Liu, Yange
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (05) : 3282 - 3292
  • [37] Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma
    Qian Zhu
    Ai-Lin Zhong
    Hao Hu
    Jing-Jing Zhao
    De-Sheng Weng
    Yan Tang
    Qiu-Zhong Pan
    Zi-Qi Zhou
    Meng-Jia Song
    Jie-Ying Yang
    Jun-Yi He
    Yuan Liu
    Min Li
    Wan-Ming Hu
    Chao-Pin Yang
    Tong Xiang
    Ming-Yuan Chen
    Gang Ma
    Ling Guo
    Jian-Chuan Xia
    Journal of Hematology & Oncology, 16
  • [38] Down-reguation of Kruppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-β1
    Yao, Shanshan
    Tian, Chuan
    Ding, Youcheng
    Ye, Qingwang
    Gao, Yong
    Yang, Ning
    Li, Qi
    ONCOTARGET, 2016, 7 (27) : 42566 - 42578
  • [39] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhenyu Zhang
    Jinfeng Zhu
    Yansong Huang
    Weibing Li
    Hongqiu Cheng
    Diagnostic Pathology, 13
  • [40] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhang, Zhenyu
    Zhu, Jinfeng
    Huang, Yansong
    Li, Weibing
    Cheng, Hongqiu
    DIAGNOSTIC PATHOLOGY, 2018, 13